Alcohol
Volume 21, Issue 1 , Pages 37-47 , May 2000

Peripheral involvement in nicotine-induced enhancement of ethanol intake

Received 14 January 1999 ,Revised 22 October 1999 ,Accepted 25 November 1999.

References 

  1. Andersson K. Mecamylamine pre-treatment counteracts cigarette smoke-induced changes in hypothalamic catecholamine neuron systems and in anterior pituitary function. Acta Physiol Scand. 1985;125:445–452
  2. Balfour DJ, Benwell ME, Graham CA, Vale AL. Behavioural and adrenocortical responses to nicotine measured in rats with selective lesions of the 5-hydroxytryptaminergic fibres innervating the hippocampus. Br J Pharmacol. 1986;89:341–347
  3. Blomqvist O. Ethanol and Central Nicotine Acetylcholine Receptors: A Behavioral and Neurochemical Study in Rodents. Göteborg: Göteborg University; 1996;Master's thesis, ISBN 91-628-2130-X
  4. Blomqvist O, Engel JA, Nissbrandt H, Söderpalm B. The mesolimbic dopamine-activating properties of ethanol are antagonized by mecamylamine. Eur J Pharmacol. 1993;249:207–213
  5. Blomqvist O, Ericson M, Engel JA, Söderpalm B. Accumbal dopamine-overflow after ethanol; localization of the antagonizing effect of mecamylamine. Eur J Pharmacol. 1997;334(2–3):149–156
  6. Blomqvist O, Ericson M, Johnson DH, Engel JA, Söderpalm B. Voluntary ethanol intake in the rat: effects of nicotinic acetylcholine receptor blockade or subchronic nicotine treatment. Eur J Pharmacol. 1996;314:257–267
  7. Bobo JK, Gilchrist LD, Schilling RF, Noach B, Schinke SP. Cigarette smoking cessation attempts by recovering alcoholics. Addict Behav. 1987;12(3):209–215
  8. Bugajski J, Gadek-Michalska A, Borycz J, Glod R. Effect of indomethacin on nicotine-induced ACTH and corticosterone response. J Physiol Pharmacol. 1998;49:165–173
  9. Collins AC, Bhat RV, Pauly JR, Marks MJ. Modulation of nicotine receptors by chronic exposure to nicotinic agonists and antagonists. In:  Bock G,  Marsh J editor. The Biology of Nicotine Dependence. Ciba Found Symp. 152:West Sussex, England: Wiley; 1990;p. 87–101ISBN 0-471-92688-4
  10. Collins AC, Burch JB, de Fibre CM, Marks MJ. Tolerance to and cross tolerance between ethanol and nicotine. Pharmacol Biochem Behav. 1988;29(2):365–373
  11. Craig TJ, Van Natta PA. The association of smoking and drinking habits in a community sample. J Stud Alcohol. 1977;38:1434–1439
  12. Deher KF, Fraser JG. Smoking habits of alcohol outpatients. Int J Addict. 1967;2:259–268
  13. DiFranza JR, Guerrera MP. Alcoholism and smoking. J Stud Alcohol. 1990;51(2):130–135
  14. Engel JA, Carlsson A. Catecholamines and behaviour. In:  Valzelli L,  Essman WB editor. Current Developments in Psychopharmacology. vol. 4:New York: Spectrum Publishing; 1977;p. 1
  15. Engel JA, Liljequist S. The involvement of different central neurotransmitters in mediating stimulatory and sedative effects of ethanol. In:  Pohorecky L,  Brick J editor. Stress and Alcohol Use. New York: Elsevier; 1983;p. 153–169
  16. Ericson M, Blomqvist O, Engel JA, Söderpalm B. Voluntary ethanol intake in the rat and the associated accumbal dopamine overflow are blocked by ventral tegmental mecamylamine. Eur J Pharmacol. 1998;358:189–196
  17. Fahlke C. Alcohol Consumption in the Rat: Modulation by Adrenal Steroids and Mesotelencephalic Dopamine. Göteborg: Göteborg University; 1994;Master's Thesis, ISSN 1101-718X
  18. Fahlke C, Engel JA, Eriksson CJP, Hård E, Söderpalm B. Involvement of corticosterone in the modulation of ethanol intake in the rat. Alcohol. 1994;11:195–202
  19. Freund RK, Martin BJ, Jungschaffer DA, Ullman EA, Collins AC. Genetic differences in plasma corticosterone levels in response to nicotine injection. Pharmacol Biochem Behav. 1988;30:1059–1064
  20. Johnson DH, Blomqvist O, Engel JA, Söderpalm B. Subchronic intermittent nicotine treatment enhances ethanol-induced locomotor stimulation and dopamine turnover in mice. Behav Pharmacol. 1995;6:203–207
  21. Kalivas PW. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Rev. 1993;18:75–113
  22. Kolta MG, Soliman KF. Effect of peripheral cholinergic activation on the adrenal cortex function. Endocr Res Commun. 1981;8:239–246
  23. Koob GF. Drugs of abuse: anatomy, pharmacology and function of reward pathways. TIPS. 1992;13:177–184
  24. Ksir C, Hakan R, Hall DP, Kellar KJ. Nicotine exposure enhances behavioral stimulant effect and increases [3H]acetylcholine binding to nicotinic receptors. Neuropharmacology. 1985;24(16):527–531
  25. Loimer N, Vedovelli H, Presslich O, Werner E, Hollerer E, Pfersmann V, et al. Nikotin-Drogensucht-AIDS. Drogengebrauchsgewohnheiten Wiener Suchtiger, Wien. Klin Wochenschr. 1991;103(20):617–620
  26. Marks MJ, Burch JB, Collins AC. Effects of chronic nicotine infusion on tolerance development and cholinergic receptors. J Pharmacol Exp Ther. 1983;226(3):817–825
  27. Nestler EJ. Molecular mechanisms of drug addiction. J Neurosci. 1992;12:2439–2450
  28. Nisell M, Nomikos GG, Svensson TH. Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse. 1994;16(1):36–44
  29. O'dell TJ, Christensen BN. Mecamylamine is a selective non-competitive antagonist of N-methyl-d-aspartate- and aspartate-induced currents in horizontal cells dissociated from the catfish retina. Neurosci Lett. 1988;94:93–98
  30. Pauly JR, Marks MJ, Robinson SF, van de Kamp JL, Collins AC. Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levels. J Pharmacol Exp Ther. 1996;278(1):361–369
  31. Potthoff AD, Ellison G, Nelson L. Ethanol intake increases during continuous administration of amphetamine and nicotine, but not several other drugs. Pharmacol Biochem Behav. 1983;18(4):489–493
  32. Rezvani AH, Overstreet DH, Janowsky DS. Reduction in ethanol preference following injection of centrally and peripherally acting antimuscarinic agents. Alcohol Alcohol. 1990;25:3–7
  33. Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev. 1993;18:247–291
  34. Sprague JE, Sharp D, Maickel RP. Cholinergic regulation of ethanol consumption in rats. Res Commun Subst Abuse. 1994;15:1–8
  35. Taylor P. Agents acting at the neuromuscular junction and autonomic ganglia. In:  Hardman JG,  Goodman Gilman A,  Limbird LE editor. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th edn.. New York: McGraw-Hill; 1996;p. 177–198
  36. Wahlström G, Nordberg A. Atropine as an inhibitor of voluntary ethanol intake in male rats. Alcohol Alcohol. 1992;27:381–391
  37. Walton RG. Smoking and alcoholism: a brief report. Am J Psychiatry. 1972;128(11):1455–1456
  38. Wise RA, Bozarth MA. A psychomotor stimulant theory of addiction. Psychol Rev. 1987;94:469–492
  39. Wise RA, Rompre P-P. Brain dopamine and reward. Annu Rev Psychol. 1989;40:191–225

PII: S0741-8329(99)00099-3

Alcohol
Volume 21, Issue 1 , Pages 37-47 , May 2000

Article Tools

* Image Usage & Resolution